• Explore /
  • Poster
  • / Development and validation of circulating tumor cell (Epic Sciences) enumeration as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

Development and validation of circulating tumor cell (Epic Sciences) enumeration as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

null

Howard I. Scher

Memorial Sloan Kettering Cancer Center, New York, NY

Howard I. Scher , Andrew J. Armstrong , Joseph D. Schonhoft , Audrey Gill , Jimmy Zhao , Ethan Barnett , Emily Carbone , James Lu , Emmanuel S. Antonarakis , Jun Luo , Scott T. Tagawa , Qian Yang , Daniel J. George , Russell Zelig Szmulewitz , Daniel Costin Danila , Rick Wenstrup , Mithat Gonen , Susan Halabi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Advanced Disease

Track

Prostate Cancer - Advanced

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 157)

DOI

10.1200/JCO.2021.39.6_suppl.157

Abstract #

157

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Johann S. De Bono

Poster

2019 Genitourinary Cancers Symposium

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

First Author: Edmond Michael Kwan

First Author: Orazio Caffo

First Author: Isabel Aragon